A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

Status:
Completed

Trial end date:
2021-07-23

Target enrollment:

Participant gender:

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-B to AD-2132 in healthy volunteers.

Phase 1

Addpharma Inc.